Search Page

1

Cite

Share

Clinical Conundrum: Dysphagia Associated with Sleep Disorders.

Iacolucci CM, Urso D, Zoccolella S, Vitulli A, Barone R, Logroscino G. Iacolucci CM, et al. Among authors: zoccolella s. Dysphagia. 2022 Jun 25. doi: 10.1007/s00455-022-10474-w. Online ahead of print. Dysphagia. 2022. PMID: 35751739 No abstract available.

Cite

Share

2

Cite

Share

Referral bias in ALS epidemiological studies.

Logroscino G, Marin B, Piccininni M, Arcuti S, Chiò A, Hardiman O, Rooney J, Zoccolella S, Couratier P, Preux PM, Beghi E; for EURALS. Logroscino G, et al. Among authors: zoccolella s. PLoS One. 2018 Apr 16;13(4):e0195821. doi: 10.1371/journal.pone.0195821. eCollection 2018. PLoS One. 2018. PMID: 29659621 Free PMC article.

Cite

Share

3

Cite

Share

Elevated homocysteine levels in Parkinson's Disease: is there anything besides L-dopa treatment?

Zoccolella S, dell'Aquila C, Specchio LM, Logroscino G, Lamberti P. Zoccolella S, et al. Curr Med Chem. 2010;17(3):213-21. doi: 10.2174/092986710790149774. Curr Med Chem. 2010. PMID: 20214564 Review.

Cite

Share

4

Cite

Share

Homocysteine levels and amyotrophic lateral sclerosis: A possible link.

Zoccolella S, Bendotti C, Beghi E, Logroscino G. Zoccolella S, et al. Amyotroph Lateral Scler. 2010;11(1-2):140-7. doi: 10.3109/17482960902919360. Amyotroph Lateral Scler. 2010. PMID: 19551535 Review.

Cite

Share

5

Cite

Share

Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies.

Zoccolella S, Savarese M, Lamberti P, Manni R, Pacchetti C, Logroscino G. Zoccolella S, et al. Sleep Med Rev. 2011 Feb;15(1):41-50. doi: 10.1016/j.smrv.2010.02.004. Epub 2010 Jul 15. Sleep Med Rev. 2011. PMID: 20634113 Review.

Cite

Share

6

Cite

Share

The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials.

Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, Millul A, Mitchell D, Preux PM, Pupillo E, Stevic Z, Swingler R, Traynor BJ, Van den Berg LH, Veldink JH, Zoccolella S; Eurals Consortium. Beghi E, et al. Among authors: zoccolella s. Amyotroph Lateral Scler. 2011 Jan;12(1):1-10. doi: 10.3109/17482968.2010.502940. Epub 2010 Aug 11. Amyotroph Lateral Scler. 2011. PMID: 20698807 Free PMC article. Review.

Cite

Share

7

Cite

Share

Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?

Zoccolella S, Lamberti SV, Iliceto G, Santamato A, Lamberti P, Logroscino G. Zoccolella S, et al. Curr Med Chem. 2010;17(28):3253-61. doi: 10.2174/092986710792232012. Curr Med Chem. 2010. PMID: 20666719 Review.

Cite

Share

8

Cite

Share

Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review.

Zoccolella S, Iliceto G, deMari M, Livrea P, Lamberti P. Zoccolella S, et al. Clin Chem Lab Med. 2007;45(12):1607-13. doi: 10.1515/CCLM.2007.337. Clin Chem Lab Med. 2007. PMID: 17963454 Review.

Cite

Share

9

Cite

Share

King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis.

Introna A, Milella G, Morea A, Ucci M, Fraddosio A, Zoccolella S, D'Errico E, Simone IL. Introna A, et al. Among authors: zoccolella s. J Neurol Sci. 2021 Dec 15;431:120041. doi: 10.1016/j.jns.2021.120041. Epub 2021 Oct 28. J Neurol Sci. 2021. PMID: 34736124

Cite

Share

10

Cite

Share

Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone.

Distaso E, Milella G, Mezzapesa DM, Introna A, D'Errico E, Fraddosio A, Zoccolella S, Dicuonzo F, Simone IL. Distaso E, et al. Among authors: zoccolella s. J Neurol. 2021 Sep;268(9):3307-3315. doi: 10.1007/s00415-021-10495-9. Epub 2021 Mar 2. J Neurol. 2021. PMID: 33655342 Free PMC article.

Cite

Share